| abstract |
Galectin 9 exhibits various biological activities in vivo. Providing a novel gene therapy agent having galectin-9 activity effectively in vivo or in cells. A gene encoding a secreted galectin-9 polypeptide, a vector having the gene, a gene therapy and / or prevention agent for a galectin-9-sensitive disease or disorder comprising the gene or the vector. It can be expected as an antitumor agent (anticancer agent), antiallergic agent, immunomodulator, autoimmune disease agent, anti-inflammatory agent and corticosteroid substitute. [Selection] Figure 7 |